TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
TFA Therapeutics's operating cash flow for the twelve months ending Dec 31, 2023 was $359.72K. For fiscal 2025 it was -$35.85K, down 111.5% from the year before. The highest annual figure on record is $359.72K in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.85K | -111.5% |
| FY2024 | Dec 31, 2024 | $312.01K | -13.3% |
| FY2023 | Dec 31, 2023 | $359.72K | – |
| FY2022 | Dec 31, 2022 | -$321.38K | – |
| FY2021 | Dec 31, 2021 | -$365.36K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$1.23M | – |
| Q4 FY2022 | Dec 31, 2022 | -$110.82K | – |
See a number that looks wrong?